| Browse Alphabetically by Name |
|
|
|
CL2273 Tandutinib(CT 53518) (387867-13-2) |
|
|
| Catalog No.: |
CL2273 |
| CAS No.: |
387867-13-2 |
| Synonym: |
MLN518,CT53518 |
| Chemical Name: |
4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide; (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide
|
| Molecular Formula: |
C31H42N6O4
|
| Molecular Weight: |
562.70 |
|
|
| Appearance: |
Yellowish powder |
| Solubility: |
Soluble in DMSO and chloroform |
| Purity: |
>99% |
| Storage: |
at -20° C |
| Original QC Data: |
|
| Shipping Conditions: |
Ambient Temp. |
|
|
| Price and Availability of Tandutinib(CT 53518): |
|
Size
|
Price
|
Stock
|
|
200 mg
|
USD 188
|
In stock
|
|
500 mg
|
USD 288
|
In stock
|
|
1 g
|
USD 528
|
In stock
|
|
Contact us for competitive discounts on bulk quantities |
|
|
An oral tyrosine kinase inhibitor (TKI), targeting FLT3 (FMS-Like Tyrosine kinase-3), c-KIT and PDGFR, thereby inhibiting cellular proliferation and inducing apoptosis.
|
1. Brownlow, N., et al. 2008. Leukemia. 22: 1452-1453. PMID: 18185521
2. DeAngelo, D.J., et al. 2006. Blood. 108: 3674-3681. PMID: 16902153 |
| View Related Products by Target: |
|